标题
Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 4, Pages 1266
出版商
MDPI AG
发表日期
2020-02-14
DOI
10.3390/ijms21041266
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence
- (2019) Marta Guerrero et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway
- (2019) Jie Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Autophagy in liver diseases: Time for translation?
- (2019) Manon Allaire et al. JOURNAL OF HEPATOLOGY
- mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars
- (2019) Gemma Sangüesa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway?
- (2019) Xiang-Nan Yu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Dysregulated autophagy and lysosome function are linked to exosome production via miR‐155 in alcoholic liver disease
- (2019) Mrigya Babuta et al. HEPATOLOGY
- Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation
- (2019) Manuel Rodríguez-Perálvarez et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK/mTOR dependent autophagy activation
- (2019) Lu Gao et al. CANCER LETTERS
- Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway
- (2019) Ge Liu et al. FASEB JOURNAL
- Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma
- (2019) Xianqiong Liu et al. Cancers
- mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma
- (2019) Ting Li et al. Cell Death & Disease
- Non-alcoholic Fatty Liver Disease Induced by Perinatal Exposure to Bisphenol a Is Associated With Activated mTOR and TLR4/NF-κB Signaling Pathways in Offspring Rats
- (2019) Ren Lin et al. Frontiers in Endocrinology
- Inducing and exploiting vulnerabilities for the treatment of liver cancer
- (2019) Cun Wang et al. NATURE
- mTOR Signalling: Jack-of-All-Trades
- (2018) Yassine El Hiani et al. Biochemistry and Cell Biology
- Drug discovery targeting the mTOR pathway
- (2018) Alberto M. Martelli et al. CLINICAL SCIENCE
- Impaired TFEB-mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-induced Liver Injury and Steatosis in Mice
- (2018) Xiaojuan Chao et al. GASTROENTEROLOGY
- The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines
- (2018) Gideon M Hirschfield et al. GUT
- Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice
- (2018) Aditi Varshney et al. HEPATOLOGY
- DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease
- (2018) Hanqing Chen et al. HEPATOLOGY
- Chronic Alcohol Consumption Inhibits Autophagy and Promotes Apoptosis in the Liver
- (2018) Mario Menk et al. International Journal of Medical Sciences
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction
- (2018) Mohamed H. Noureldein et al. MICROBIAL PATHOGENESIS
- Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
- (2018) Manuel Rodríguez-Perálvarez et al. TRANSPLANTATION
- Two-Step Senescence-Focused Cancer Therapies
- (2018) Cynthia J. Sieben et al. TRENDS IN CELL BIOLOGY
- Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice
- (2018) Shoji Yamada et al. Oncotarget
- Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR
- (2018) Susana Llerena et al. Oncotarget
- Dynamic MTORC1-TFEB feedback signaling regulates hepatic autophagy, steatosis and liver injury in long-term nutrient oversupply
- (2018) Hao Zhang et al. Autophagy
- NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway
- (2018) Youcai Tang et al. PLoS One
- mTOR-dependent phosphorylation controls TFEB nuclear export
- (2018) Gennaro Napolitano et al. Nature Communications
- Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis
- (2018) Elena V. Polishchuk et al. GASTROENTEROLOGY
- The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance
- (2018) Fei Han et al. Nature Communications
- Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma
- (2017) Sufang Yang et al. Oncology Letters
- mTORC1 signaling in hepatic lipid metabolism
- (2017) Jinbo Han et al. Protein & Cell
- Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
- (2016) D. Koeberle et al. ANNALS OF ONCOLOGY
- Targeting Signalling Pathways in Hepatocellular carcinoma
- (2016) Kaja Blagotinšek et al. CURRENT PHARMACEUTICAL DESIGN
- PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
- (2016) Vivek Asati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of Liver Metabolism by Autophagy
- (2016) Julio Madrigal-Matute et al. GASTROENTEROLOGY
- Cancer metabolism: a therapeutic perspective
- (2016) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- Killing Two Birds With One Stone
- (2016) Elizabeth A. Pomfret TRANSPLANTATION
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Acute and Chronic Ethanol Administration Differentially Modulate Hepatic Autophagy and Transcription Factor EB
- (2015) Paul G. Thomes et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- GCDCA down-regulates gene expression by increasing Sp1 binding to the NOS-3 promoter in an oxidative stress dependent manner
- (2015) Sandra González-Rubio et al. BIOCHEMICAL PHARMACOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation
- (2014) M. Sterneck et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus Inhibits Anti-HLA I Antibody-Mediated Endothelial Cell Signaling, Migration and Proliferation More Potently Than Sirolimus
- (2014) Y.-P. Jin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- De NovoSirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000-2003 Phase II Prospective Randomized Trial
- (2014) S. K. Asrani et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
- (2014) Feng Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
- (2014) Ramona Rudalska et al. NATURE MEDICINE
- U12, a UDCA Derivative, Acts as an Anti-Hepatoma Drug Lead and Inhibits the mTOR/S6K1 and Cyclin/CDK Complex Pathways
- (2014) Yang Xu et al. PLoS One
- Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review
- (2014) Evangelos Cholongitas et al. TRANSPLANT INTERNATIONAL
- Is Cancer a Metabolic Disease?
- (2013) Hilary A. Coller AMERICAN JOURNAL OF PATHOLOGY
- Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway
- (2013) Gang Wan et al. Autophagy
- Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease
- (2013) Brice Sid et al. BIOCHEMICAL PHARMACOLOGY
- The mTOR pathway in hepatic malignancies
- (2013) Mamatha Bhat et al. HEPATOLOGY
- Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma
- (2013) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice
- (2013) Chih-Wen Lin et al. JOURNAL OF HEPATOLOGY
- Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
- (2013) Matthias S. Matter et al. JOURNAL OF HEPATOLOGY
- Everolimus With Reduced Tacrolimus Improves Renal Function inDe NovoLiver Transplant Recipients: A Randomized Controlled Trial
- (2012) P. De Simone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis
- (2012) A. Roczniak-Ferguson et al. Science Signaling
- Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice
- (2012) S. Menon et al. Science Signaling
- mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma
- (2012) H. E. Thomas et al. Science Translational Medicine
- Mammalian TOR signaling to the AGC kinases
- (2011) Bing Su et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway
- (2011) Yotaro Kudo et al. JOURNAL OF HEPATOLOGY
- Autophagy Required for Hepatitis B Virus Replication in Transgenic Mice
- (2011) Y. Tian et al. JOURNAL OF VIROLOGY
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- Resveratrol Inhibits Protein Translation in Hepatic Cells
- (2011) Eugenia Villa-Cuesta et al. PLoS One
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
- (2011) V. S. Rodrik-Outmezguine et al. Cancer Discovery
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- mTOR regulation of autophagy
- (2010) Chang Hwa Jung et al. FEBS LETTERS
- Autophagy Reduces Acute Ethanol-Induced Hepatotoxicity and Steatosis in Mice
- (2010) Wen–Xing Ding et al. GASTROENTEROLOGY
- A comprehensive map of the mTOR signaling network
- (2010) Etienne Caron et al. Molecular Systems Biology
- Autophagy in viral replication and pathogenesis
- (2010) Donna Sir et al. MOLECULES AND CELLS
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
- (2009) Ledu Zhou et al. MEDICAL ONCOLOGY
- Autophagy regulates lipid metabolism
- (2009) Rajat Singh et al. NATURE
- Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a Signaling Pathway Important for Normal and Cancer Cell Growth
- (2009) James J. Gibbons et al. SEMINARS IN ONCOLOGY
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
- (2008) Jingxiang Huang et al. BIOCHEMICAL JOURNAL
- Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells
- (2008) Sakiko Arisawa et al. BIOCHEMICAL PHARMACOLOGY
- Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma
- (2008) C.-J. Yen et al. CANCER RESEARCH
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
- (2008) Arkaitz Carracedo et al. JOURNAL OF CLINICAL INVESTIGATION
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- AMPK and Raptor: Matching Cell Growth to Energy Supply
- (2008) D. Grahame Hardie MOLECULAR CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now